Breast Cancer Clinical Trial

Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL

Summary

The purpose of this study is to determine whether patients experience a better quality of life when they have received education about coping strategies for cognitive dysfunction.

View Full Description

Full Description

Cancer treatment may consist of chemotherapy, radiation, hormone therapy, surgery or a combination of all disciplines. However, breast cancer therapies have at times demonstrated distressing effects in patients/survivors during and/or following treatment. One area that is found to cause distress for the breast cancer patient is changes in cognitive function.

Areas most commonly impacted by changes in cognitive function as a result of chemotherapy include executive functioning (including judgment, hindsight and foresight), processing speed or reaction time, working memory, and organizational skills.

Due to the limited amount of research involving quality of life as related to cognitive dysfunction, there is a clear need for additional investigation. Treatment typically focuses on the physical and psychosocial aspects of patients/survivors, however emphasis should also be placed on the impact of quality of life during treatment and survivorship due to the potential for far-reaching effects as previously discussed.

Oncology nurses may be instrumental in identifying patients with Cognitive Dysfunction. In doing so, the nurse may then communicate with the patient/survivor as to the impact of Cognitive Dysfunction on quality of life. The nurse can provide appropriate education and or additional support options.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age >18years old
Stage 0-IV breast cancer (excluding stage IV with metastasis to the brain)
Life expectancy > 3 months
Able to speak and read English fluently
Self-reported cognitive difficulties that interfere with everyday activities
Reported Memory/Cognitive changes on Distress Thermometer
Able to provide written and informed consent
Willing to complete FACT-Cog questionnaire

Exclusion Criteria:

Current Cognitive Training, for example, use of brain training, physical therapy, occupational or speech therapy for the sole purpose of improving cognitive function
Recent diagnosis of Major depression or other current psychiatric disorders and are not considered stable per a current care provider
History of Dementia or Alzheimer's Disease
History of Central Nervous System (CNS) radiation, intrathecal chemotherapy, or CNS involved surgery
History of metastatic disease extending to the brain
History of traumatic brain injury
History of seizure disorder
History of thyroid disorder (Subjects that are well managed without changes in thyroid medications or doses for at least 6 months may participate in study)
Current use of illicit substances and or alcohol (including medical marijuana)
Current sleep disturbance/disorder (Subjects that are well managed without changes in sleep medications or doses for at least 6 months may participate in study).
Concurrent use of antidepressants for example, use of antidepressants for pain management or smoking cessation. (Subjects that are well managed without changes on antidepressant medications or doses for at least 6 months may participate in study).

Study is for people with:

Breast Cancer

Estimated Enrollment:

100

Study ID:

NCT03476226

Recruitment Status:

Unknown status

Sponsor:

Advocate Health Care

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

Advocate Good Shepherd Hospital
Barrington Illinois, 60010, United States
Advocate Illinois Masonic Medical Center
Chicago Illinois, 60657, United States
Advocate Sherman Hospital
Elgin Illinois, 60123, United States
Advocate South Suburban Hospital
Hazel Crest Illinois, 60429, United States
Advocate Condell Medical Center
Libertyville Illinois, 60048, United States
Advocate Lutheran General Hospital
Park Ridge Illinois, 60068, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

100

Study ID:

NCT03476226

Recruitment Status:

Unknown status

Sponsor:


Advocate Health Care

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider